Should repair of partial atrioventricular septal defect be delayed until later in childhood?

Jessica L Bowman1, Joseph A Dearani2, Harold M Burkhart2

  • 1Section of Cardiology, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio; Division of Pediatric Cardiology, Mayo Clinic College of Medicine, Rochester, Minnesota.

Insights

Surgical repair of partial atrioventricular septal defects (AVSD) shows good long-term outcomes. Elective repair in older children (5-8 years) may reduce left atrioventricular valve regurgitation (LAVVR) complications.

Area of Science:

  • Pediatric Cardiac Surgery
  • Congenital Heart Disease Research
  • Cardiovascular Outcomes

Background:

  • Surgical repair of partial atrioventricular septal defects (AVSD) has a long history of success.
  • Recent data indicate a significant incidence of moderate to severe left atrioventricular valve regurgitation (LAVVR) post-repair.
  • Previous institutional findings suggested a lower LAVVR rate compared to national data.

Purpose of the Study:

  • To evaluate the long-term outcomes of primary biventricular repair for partial AVSD.
  • To compare institutional outcomes with national data regarding LAVVR after AVSD repair.
  • To identify optimal timing for elective partial AVSD repair.

Main Methods:

  • Retrospective review of 105 patients undergoing primary biventricular repair for partial AVSD (1995-2011).
  • Kaplan-Meier survival analysis for overall survival and freedom from reoperation.
  • Log-rank test used to assess risk factors for adverse outcomes.

Main Results:

  • Overall survival at 1 year was 97%.
  • Survival free from reoperation at 3 years was 89%, with LAVVR being the most common reason for reoperation.
  • Cumulative incidence of more than moderate LAVVR by 2 years was 8% in this cohort.
  • Later age at surgery (5-8 years) in this cohort may explain lower LAVVR rates compared to other studies.

Conclusions:

  • Surgical repair of partial AVSD demonstrates favorable long-term survival and acceptable rates of LAVVR.
  • Deferred elective repair, between ages 5 and 8 years, may be associated with improved outcomes regarding LAVVR.
  • Patient age and preoperative LAVVR severity were not statistically significant risk factors in this study.

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.9K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
511
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
670
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
550
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801